Clinical Trial Update: A Research Study Looking Into Blood Levels of the Medicine NNC0487-0111 in the Body and How Well it is Tolerated in Participants With Reduced Kidney Function and Normal Kidney Function [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic and tolerability study of NNC0487-0111 in participants with reduced and normal kidney function has completed. The study targeted individ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• NNC0487-0111

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2, Obesity | Phase 1 | Status: COMPLETED